Primary Cause of Death by 1 Year Post–Hematopoietic Cell Transplantation of Patients With Vancomycin-resistant Enterococcus Bloodstream Infection (VRE BSI), non-VRE BSI, and Without BSI by Day 100
| Variable . | VRE BSI, N (%) . | Non-VRE BSI, N (%) . | Without BSI, N (%) . |
|---|---|---|---|
| Patients who died by 1 year post hematopoietic cell transplantation | 192 (74) | 1063 (44) | 1519 (34) |
| Relapse (recurrent/persistent disease) | 47 (24) | 440 (41) | 807 (53) |
| Organ failure | 49 (26) | 166 (16) | 223 (15) |
| Infection | 29 (15) | 195 (18) | 182 (12) |
| Graft versus host disease | 28 (15) | 125 (12) | 145 (10) |
| Other cause | 19 (10) | 48 (5) | 65 (4) |
| Hemorrhage | 8 (4) | 27 (3) | 26 (2) |
| Idiopathic pneumonitis | 5 (3) | 19 (2) | 22 (1) |
| Graft rejection | 5 (3) | 23 (2) | 21 (1) |
| Unknown | 2 (1) | 12 (1) | 18 (1) |
| Secondary malignancy | 0 | 8 (<1) | 10 (<1) |
| Variable . | VRE BSI, N (%) . | Non-VRE BSI, N (%) . | Without BSI, N (%) . |
|---|---|---|---|
| Patients who died by 1 year post hematopoietic cell transplantation | 192 (74) | 1063 (44) | 1519 (34) |
| Relapse (recurrent/persistent disease) | 47 (24) | 440 (41) | 807 (53) |
| Organ failure | 49 (26) | 166 (16) | 223 (15) |
| Infection | 29 (15) | 195 (18) | 182 (12) |
| Graft versus host disease | 28 (15) | 125 (12) | 145 (10) |
| Other cause | 19 (10) | 48 (5) | 65 (4) |
| Hemorrhage | 8 (4) | 27 (3) | 26 (2) |
| Idiopathic pneumonitis | 5 (3) | 19 (2) | 22 (1) |
| Graft rejection | 5 (3) | 23 (2) | 21 (1) |
| Unknown | 2 (1) | 12 (1) | 18 (1) |
| Secondary malignancy | 0 | 8 (<1) | 10 (<1) |
Infection was a secondary/contributing cause of death: VRE BSI = 45 (23%), non-VRE BSI = 187 (18%), without BSI = 215 (14%).
Primary Cause of Death by 1 Year Post–Hematopoietic Cell Transplantation of Patients With Vancomycin-resistant Enterococcus Bloodstream Infection (VRE BSI), non-VRE BSI, and Without BSI by Day 100
| Variable . | VRE BSI, N (%) . | Non-VRE BSI, N (%) . | Without BSI, N (%) . |
|---|---|---|---|
| Patients who died by 1 year post hematopoietic cell transplantation | 192 (74) | 1063 (44) | 1519 (34) |
| Relapse (recurrent/persistent disease) | 47 (24) | 440 (41) | 807 (53) |
| Organ failure | 49 (26) | 166 (16) | 223 (15) |
| Infection | 29 (15) | 195 (18) | 182 (12) |
| Graft versus host disease | 28 (15) | 125 (12) | 145 (10) |
| Other cause | 19 (10) | 48 (5) | 65 (4) |
| Hemorrhage | 8 (4) | 27 (3) | 26 (2) |
| Idiopathic pneumonitis | 5 (3) | 19 (2) | 22 (1) |
| Graft rejection | 5 (3) | 23 (2) | 21 (1) |
| Unknown | 2 (1) | 12 (1) | 18 (1) |
| Secondary malignancy | 0 | 8 (<1) | 10 (<1) |
| Variable . | VRE BSI, N (%) . | Non-VRE BSI, N (%) . | Without BSI, N (%) . |
|---|---|---|---|
| Patients who died by 1 year post hematopoietic cell transplantation | 192 (74) | 1063 (44) | 1519 (34) |
| Relapse (recurrent/persistent disease) | 47 (24) | 440 (41) | 807 (53) |
| Organ failure | 49 (26) | 166 (16) | 223 (15) |
| Infection | 29 (15) | 195 (18) | 182 (12) |
| Graft versus host disease | 28 (15) | 125 (12) | 145 (10) |
| Other cause | 19 (10) | 48 (5) | 65 (4) |
| Hemorrhage | 8 (4) | 27 (3) | 26 (2) |
| Idiopathic pneumonitis | 5 (3) | 19 (2) | 22 (1) |
| Graft rejection | 5 (3) | 23 (2) | 21 (1) |
| Unknown | 2 (1) | 12 (1) | 18 (1) |
| Secondary malignancy | 0 | 8 (<1) | 10 (<1) |
Infection was a secondary/contributing cause of death: VRE BSI = 45 (23%), non-VRE BSI = 187 (18%), without BSI = 215 (14%).
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
